Interferon Gamma-Induced Protein (IP-10) as Potential Biomarker for Cancer-Related-Fatigue: Results from a 6-month Randomized Controlled Trial

There is no fulltext present in this item.

Title:	Interferon Gamma-Induced Protein (IP-10) as Potential Biomarker for Cancer-Related-Fatigue: Results from a 6-month Randomized Controlled Trial
Author(s):	Veer, Emil ter; Prinsen, Hetty; Sprangers, M.A.G. ; Zwinderman, Koos A.H.; Bleijenberg, G. ; Kraan, Tineke C.T.M.van der Pouw; Vries, I.J.M. de ; Wierenga, Eddy A.; Laarhoven, H.W.M. van
Publication year:	2018
Source:	Cancer Investigation, vol. 36, iss. 7, (2018), pp. 371-377
ISSN:	0735-7907
DOI:	https://doi.org/10.1080/07357907.2018.1499933
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/196911
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 2: Cancer development and immune defence RIHS: Radboud Institute for Health Sciences Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience Tijdelijke code tbv inlezen publicaties Radboudumc - Alleen voor gebruik door Radboudumc
Organization:	Radboudumc Extern Medical Psychology Medical Oncology Tumorimmunology
Journal title:	Cancer Investigation
Volume:	vol. 36
Issue:	iss. 7
Page start:	p. 371
Page end:	p. 377